Page 38 - Exact Sciences News Today

KNOW YOUR MADISONIAN | BEN CHULAWAN

Exact Sciences Co. (NASDAQ:EXAS – Free Report) – Stock analysts at Leerink Partnrs decreased their FY2025 earnings estimates for Exact Sciences in a research report issued to clients and investors on Wednesday, August 2nd. Leerink Partnrs analyst P. Souda now anticipates that the medical research company will post earnings per share of $0.83 for the […]

Exact Sciences (NASDAQ:EXAS – Free Report) had its target price increased by Robert W. Baird from $99.00 to $121.00 in a report published on Wednesday, MarketBeat.com reports. Robert W. Baird currently has an outperform rating on the medical research company’s stock. EXAS has been the topic of a number of other reports. Citigroup raised their […]

A dream trip on Amtraks Empire Builder took a tragic turn in 2021, and last month Ben Chulawan was rewarded with the Soldiers Medal for helping fellow passengers.

Exact Sciences (NASDAQ:EXAS – Free Report) had its target price raised by Credit Suisse Group from $75.00 to $90.00 in a research note issued to investors on Wednesday, Marketbeat.com reports. Credit Suisse Group currently has a neutral rating on the medical research company’s stock. Other analysts also recently issued reports about the stock. StockNews.com started […]

Alpha DNA Investment Management LLC acquired a new position in Exact Sciences Co. (NASDAQ:EXAS – Free Report) in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor acquired 15,342 shares of the medical research company’s stock, valued at approximately $1,040,000. Other hedge funds and […]

In this article, we discuss 12 best biotech ETFs to buy. If you want to skip our detailed discussion on the biotech industry, head directly to 5 Best Biotech ETFs To Buy. According to Precedence Research, the worldwide biotechnology market was valued at approximately $1,224.31 billion in 2022. It is projected to reach a value […]

According to Precedence Research, the worldwide biotechnology market was valued at approximately $1,224.31 billion in 2022.

Exact Sciences Corporation (NASDAQ:EXAS) Q2 2023 Earnings Call Transcript August 1, 2023 Exact Sciences Corporation beats earnings expectations. Reported EPS is $-0.45, expectations were $-0.51. Operator: Good day and welcome to the Exact Sciences Second Quarter 2023 Earnings Call. Today’s call is being recorded. All lines have been placed on mute to prevent any background […]

Achmea Investment Management B.V. raised its stake in Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 3,322.4% in the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 10,986 shares of the medical research company’s stock after acquiring an additional 10,665 shares during the […]